Ki-67 in Pulmonary Neuroendocrine Tumors: Where Do We Stand?

PCI Decreases the Risk of Brain Metastases in Patients with Locally Advanced NSCLC

What Can We Offer a Patient with a Malignant Mesothelioma?

2019 IASLC Best of the World Lung Cancer Conference Results in New Virtual Collaboration

The IASLC and the International Thoracic Oncology Nursing Forum: Celebrating Collaboration

IASLC 2019 Mesothelioma Meeting Offers Innovative Approach for Rapid Learning

IASLC Targeted Therapies of Lung Cancer Meeting Draws Record Abstract Submissions, Attendance

Checkpoint Inhibitors and Clinical Decision Making: A Q&A with Dr. Nasser H. Hanna

Scott Antonia, MD, PhD

Charles B. Simone, II, MD

FDA’s New Acting Commissioner